Skip to content
Rajnish Wellness logo

Rajnish Wellness

541601 BSE
₹0.36

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹0.36 −0.41 −53.2% 1Y
Start ₹0.77

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
−8.99%
Debt to Equity
0.00
EPS (TTM)
−₹0.06
Book Value
₹1.01
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
0.36
ROE
−6.74%
Dividend Yield
0.00%
EBITDA
−₹8.40 Cr
52W High
₹0.90
52W Low
₹0.32

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

48 Average

Data confidence 88/100

Category scores

Quality
31
Poor
Returns, margins, earnings quality 22% weight
Valuation
45
Weak
Cheap vs sector & own history 24% weight
Growth
99
Strong
Sales & profit trajectory 9% weight
Financial Health
75
Strong
Solvency, leverage, coverage 9% weight
Momentum
22
Poor
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is almost debt free.
  • Stock is trading at 0.36 times its book value
  • Debtor days have improved from 137 to 49.7 days.

Weaknesses

4
  • Company has low interest coverage ratio.
  • Promoter holding is low: 9.16%
  • Company has a low return on equity of -1.95% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.08%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1063
OscillatorsBearish360
Moving AveragesStrong Bearish703

Key readings

RSI (14)
49.18
Neutral
MACD (12,26,9)
−0.01
Bearish
SMA (50)
0.38
Bearish
SMA (200)
0.44
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+61.31%
3Y+76.10%
1Y+189.80%
TTM+356.94%

Net profit

Net profit growth by window
5YTurned to loss
3YTurned to loss
1YTurned to loss
TTMTurned to loss

Operating cash flow

Operating cash flow growth by window
5YTurned negative
3YOutflow narrowed by ₹53 Cr
1YOutflow widened by ₹5 Cr
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y+16.74 pp
3Y−2.49 pp
1Y−6.34 pp
TTM−5.47 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹25.00 Cr
Mar 2018₹28.00 Cr
Mar 2019₹42.00 Cr
Mar 2020₹14.00 Cr
Mar 2021₹13.00 Cr
Mar 2022₹26.00 Cr
Mar 2023₹26.00 Cr
Mar 2024₹77.00 Cr
Mar 2025₹49.00 Cr
Mar 2026₹142 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹1.00 Cr
Mar 2018₹2.00 Cr
Mar 2019₹4.00 Cr
Mar 2020−₹1.00 Cr
Mar 2021₹0.00 Cr
Mar 2022₹0.00 Cr
Mar 2023₹0.00 Cr
Mar 2024₹1.00 Cr
Mar 2025₹0.00 Cr
Mar 2026−₹6.00 Cr

Quarterly Results

₹ Cr
541601 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
8.51
18.51
21.62
26.98
16.3
17.42
9.06
5.77
4.56
12
23.24
102
31.01
Expenses
8.48
18.47
21.33
26.44
16.29
16.94
8.92
6.38
4.39
12.22
24.61
109
30.96
Operating Profit
0.03
0.04
0.29
0.54
0.01
0.48
0.14
−0.61
0.17
−0.22
−1.37
−6.84
0.05
OPM %
0.35%
0.22%
1.34%
2%
0.06%
2.76%
1.55%
−10.57%
3.73%
−1.83%
−5.9%
−6.71%
0.16%
Other Income
0.83
0.23
0
0
0.35
0
0.01
0.16
0.12
0.31
0.37
0.02
0.08
Interest
0.13
0.14
0.12
0.11
0.13
0.1
0.04
0
0
0
0
0
0
Depreciation
0
0
0
0.01
0
0.01
0.01
0.01
0
0
0.01
0.01
0.01
PBT
0.73
0.13
0.17
0.42
0.23
0.37
0.1
−0.46
0.29
0.09
−1.01
−6.83
0.12
Tax %
24.66%
23.08%
35.29%
30.95%
26.09%
24.32%
20%
0%
27.59%
22.22%
−9.9%
−31.19%
0%
Net Profit
0.55
0.1
0.1
0.28
0.17
0.28
0.07
−0.46
0.22
0.06
−0.91
−4.7
0.12
EPS (₹)
0
0
0
0
0
0
0
0
0
0
−0.01
−0.05
0

Profit & Loss

₹ Cr
541601 profit and loss, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
25
28
42
14
13
26
26
77
49
142
168
Expenses
24
24
35
14
17
27
27
75
49
151
177
Operating Profit
1
3
7
0
−3
0
−1
2
0
−9
−8
OPM %
4.7%
12%
16%
1%
−24%
−0.7%
−4.3%
2.6%
0%
−6%
−5%
Other Income
0
1
0
0
4
1
2
0
1
1
1
Interest
0
1
1
1
0
0
0
1
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
PBT
1
4
6
−1
0
0
1
1
0
−8
−8
Tax %
33%
33%
28%
−2%
18%
15%
27%
29%
25%
−25%
—
Net Profit
1
2
4
−1
0
0
0
1
0
−6
−5
EPS (₹)
0.94
0.06
0.08
−0.01
0
0.01
0
0.01
0
−0.06
−0.06
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
541601 balance sheet, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.05
3
5
5
5
11
77
77
77
102
Reserves
1
3
18
17
17
12
6
7
7
1
Borrowings
3
4
5
8
0
0
10
5
0
0
Other Liabilities
5
8
5
4
13
13
6
17
7
6
Total Liabilities
8
18
32
33
35
35
99
106
91
109
Fixed Assets
0
0
0
0
0
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
3
8
Other Assets
8
18
32
33
35
35
99
106
88
101
Total Assets
8
18
32
33
35
35
99
106
91
109

Cash Flow

₹ Cr
541601 cash flow, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−2
−3
−9
−7
0
0
−62
2
−4
−9
Investing
0
0
0
0
0
0
0
0
9
−7
Financing
1
3
10
5
0
1
62
−2
−5
25
Net Cash Flow
0
0
1
−1
0
1
−1
0
0
9
Free Cash Flow
−2
−3
−9
−7
0
0
−62
2
−4
−9
CFO/OP
−136
−90
−118
−4,650
−4
−32
5,577
105
−41,900
94

Ratios

541601 financial ratios, annual
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
59
182
164
318
460
224
287
160
201
50
Inventory Days
152
75
77
48
27
32
59
48
79
35
Days Payable
121
145
27
56
50
17
55
78
31
7
Cash Conversion Cycle
90
111
214
310
436
238
290
130
249
77
Working Capital Days
30
102
183
702
791
407
449
305
530
182
ROCE %
—
65%
37%
1%
2%
3%
1%
2%
1%
−9%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Rajnish Wellness insights

57 extracted metrics across FY16–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 85.18%
  • Promoters 9.16%
  • Others 5.23%
  • FIIs 0.43%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Rajnish Wellness

What does Rajnish Wellness Ltd do?
Incorporated in 2015, Rajnish Wellness Ltd manufactures and sells various ayurvedic medicinal products.
Where is Rajnish Wellness Ltd (RAJNISH) listed?
Rajnish Wellness Ltd trades under code 541601 on the BSE.
Which sector does Rajnish Wellness Ltd belong to?
Rajnish Wellness Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the 52-week high and low of Rajnish Wellness Ltd?
Over the last 52 weeks Rajnish Wellness Ltd has traded between ₹0.32 and ₹0.9 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Rajnish Wellness Ltd?
Rajnish Wellness Ltd reported a return on equity of -6.74%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 2015, Rajnish Wellness Ltd manufactures and sells various ayurvedic medicinal products.

Website rajnishwellness.com
CEO Mr. Rajnishkumar Surendra Prasad Singh
Employees 17
Listed 9 Jul 2018
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/541601.md for Rajnish Wellness Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month